✨
AI Summary
- Sam Altman testified before the Senate, discussing AI's potential and regulatory challenges.
- The episode covered regulatory capture and the comparison of AI's potential impact to nuclear weapons.
- Lina Khan's move to block Amgen's acquisition of Horizon Therapeutics was also discussed.